Dock2 participates in bone marrow lympho-hematopoiesis

Tomoko Kikuchi, Shiro Kubonishi, Misako Shibakura, Noriko Namba, Toshimitsu Matsui, Yoshinori Fukui, Mitsune Tanimoto, Yoshio Katayama

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)


Dock2 has been shown to be indispensable for chemotaxis of mature lymphocytes as a critical Rac activator. However, the functional expression of Dock2 in immature hematopoietic cells is unclear. In this study, we demonstrate that Dock2 is broadly expressed in bone marrow (BM) hematopoietic compartment, including hematopoietic stem/progenitor cell (HSC/HPC) fraction. Response of Dock2-/- HPCs to CXCL12 in chemotaxis and actin polymerization in vitro was impaired, although α4 integrin activation by CXCL12 was not altered. Myelosuppressive stress on HSCs in vivo, such as consecutive 5-FU administration and serial bone marrow transplantation, did not show hematopoietic defect in Dock2-/- mice. Long-term engraftment of transplanted Dock2-/- BM cells was severely impaired in competitive reconstitution. However, this was not intrinsic to HSCs but originated from the defective competition of Dock2-/- lymphoid precursors. These results suggest that Dock2 plays a significant role in BM lymphopoiesis, but is dispensable for HSC engraftment and self-renewal.

Original languageEnglish
Pages (from-to)90-96
Number of pages7
JournalBiochemical and Biophysical Research Communications
Issue number1
Publication statusPublished - Feb 29 2008
Externally publishedYes


  • CXCL12
  • CXCR4
  • Dock2
  • Hematopoietic stem/progenitor cells

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Dock2 participates in bone marrow lympho-hematopoiesis'. Together they form a unique fingerprint.

Cite this